{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:03:53Z","timestamp":1768410233799,"version":"3.49.0"},"reference-count":28,"publisher":"American Society of Consultant Pharmacists","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2014,4,1]]},"DOI":"10.4140\/tcp.n.2014.264","type":"journal-article","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T02:51:40Z","timestamp":1396666300000},"page":"264-269","source":"Crossref","is-referenced-by-count":12,"title":["Dextromethorphan\/Quinidine for the Treatment of Pseudobulbar Affect"],"prefix":"10.4140","volume":"29","author":[{"given":"Edna","family":"Patatanian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Casselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.21056","article-title":"A real reason for patients with pseudobulbar affect to smile","volume":"61","author":"HJ Rosen","year":"2007","journal-title":"Ann Neurol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/ern.11.68","article-title":"Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments","volume":"11","author":"A Miller","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2006.06.030","article-title":"Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect","volume":"259","author":"A Miller","year":"2007","journal-title":"J Neurol Sci"},{"key":"4","first-page":"1","article-title":"The differential diagnosis of pseudobulbar affect (PBA)","author":"DB Arciniegas","year":"2005","journal-title":"Roundtable Monograph Supplement"},{"key":"5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jns.2008.04.017","article-title":"Brain responses to verbal stimuli among multiple sclerosis patients with pseudobulbar affect","volume":"271","author":"G Haiman","year":"2008","journal-title":"J Neurol Sci"},{"key":"6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/appi.neuropsych.17.4.447","article-title":"Review of pseudobulbar affect including a novel and potential therapy","volume":"17","author":"R Schiffer","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"7","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4065\/81.11.1482","article-title":"Diagnosis and management of pathological laughter and crying","volume":"81","author":"J Parvizi","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/1352458504ms1106oa","article-title":"Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients","volume":"10","author":"RA Smith","year":"2004","journal-title":"Mult Scler"},{"key":"9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2005.09.018","article-title":"Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies","volume":"245","author":"A Miller","year":"2006","journal-title":"J Neurol Sci"},{"key":"10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ana.22093","article-title":"Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect","volume":"68","author":"EP Pioro","year":"2010","journal-title":"Ann Neurol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0003-9993(96)90198-7","article-title":"Pathological crying and laughing: treatment with sertraline","volume":"77","author":"J Mukand","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"12","first-page":"184","article-title":"Pathological laughter: common vs. unusual aetiology and presentation","volume":"35","author":"A Arlazaroff","year":"1998","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.yebeh.2006.01.017","article-title":"Du rire aux larmes: Pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine","volume":"8","author":"LM Chahine","year":"2006","journal-title":"Epilepsy Behav"},{"key":"14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.apmr.2007.09.032","article-title":"Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases","volume":"89","author":"S Sacco","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1017\/S1461145709990745","article-title":"Duloxetine for pathological laughing and crying","volume":"12","author":"P Ferentinos","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/WNF.0b013e3181f6bfbe","article-title":"Effectiveness of quetiapine for poststroke pathological laughing: case report and review of the literature","volume":"33","author":"YR Chen","year":"2010","journal-title":"Clin Neuropharm"},{"key":"17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jocn.2011.07.006","article-title":"Treatment of pseudobulbar affect with citalopram in a patient with progressive multifocal leukoencephalopathy","volume":"19","author":"RR King","year":"2012","journal-title":"J Clin Neurosci"},{"key":"18","first-page":"1480","article-title":"Treatment of ballism and pseudobulbar affect with sertraline. Arch Neurol 2001;58:1682-4. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline","volume":"312","author":"MS Okun","year":"1985","journal-title":"N Engl J Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/02699059209029668","article-title":"Fluoxetine improves emotional incontinence","volume":"6","author":"GM Seliger","year":"1992","journal-title":"Brain Injury"},{"key":"20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.150.2.286","article-title":"Pathological laughing and crying following stroke: validation of a measurement scale and a doubleblind treatment study","volume":"150","author":"RG Robinson","year":"1993","journal-title":"Am J Psychiatry"},{"key":"21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0140-6736(93)92696-Q","article-title":"Citalopram for post-stroke pathological crying","volume":"342","author":"G Andersen","year":"1993","journal-title":"Lancet"},{"key":"22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0447.1998.tb10119.x","article-title":"Fluoxetine as a treatment for poststroke emotionalism","volume":"98","author":"KW Brown","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO;2-Z","article-title":"Sertraline in strokeassociated lability of mood","volume":"14","author":"A Burns","year":"1999","journal-title":"Int J Geriat Psychiatry"},{"key":"24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/026990599121197","article-title":"Paroxetine versus citalopram treatment of pathological crying after brain injury","volume":"13","author":"U Muller","year":"1999","journal-title":"Brain Injury"},{"key":"25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.STR.0000190892.93663.e2","article-title":"Fluoxetine treatment in post-stroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study","volume":"37","author":"S Choi-Kwon","year":"2006","journal-title":"Stroke"},{"key":"26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","article-title":"Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine","volume":"63","author":"BR Brooks","year":"2004","journal-title":"Neurology"},{"key":"27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.20828","article-title":"Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis","volume":"59","author":"HS Panitch","year":"2006","journal-title":"Ann Neurol"},{"key":"28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/JCP.0b013e3181b5ae5c","article-title":"Effects of dextromethorphan\/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect","volume":"29","author":"G Haiman","year":"2009","journal-title":"J Clin Psychopharmacol"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T08:06:53Z","timestamp":1565338013000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2014\/00000029\/00000004\/art00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4,1]]}},"alternative-id":["C652695M34524W48"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2014.264","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}